Which Pharma Product Websites are Driving Consumers to the Doctor to Request Prescriptions?

Manhattan ResearchPharmaceutical and healthcare market research company Manhattan Research recently released the ePharma Consumer® v10.0 study, which explores the online behaviors of ePharma Consumers, or U.S. consumers using the Internet for prescription drug information. The study also provides in-depth metrics for hundreds of pharma product websites, including satisfaction, reasons for visiting, and post-visitation actions, as well as adoption and interest for various types of online resources and services from pharma.

The study found that pharma product websites are effective at driving post-visitation action. 74%* of ePharma Consumers visiting these websites take a product-related action afterward - either discussing product info with their doctor, family or friends; requesting or filling the prescription; or searching for more product info online.

Among the more than 320 pharma product websites tracked in the study, the brand website of erectile dysfunction treatment Levitra® was the most likely to drive visitors to request a prescription for the drug from their doctor. The brand websites for Chantix®, Cialis®, Nexium®, and Yaz® round out the top five most likely to drive visitors to request prescriptions.

A common theme among top websites is content and structure designed to lead consumers to talk to their doctor. Additionally, many of these products, such as the sleep aid Lunesta® and the acid reflux treatment Nexium®, feature doctor discussion guides or worksheets on their websites.

Top Pharma Product Websites Driving Visitors to Request that Prescription from the Doctor

1. Levitra®
2. Chantix®
3. Cialis®
4. Nexium®
5. Yaz®
6. Lyrica®
7. NuvaRing®
8. Symbicort®
9. Viagra®
10. Lunesta®

Websites with the highest percent of visitors responding that they "requested a prescription for this product from a doctor" after visiting website for themselves; Among U.S. adults ages 18+ online for pharma information and websites for which n>60

* Industry average of aided responses across more than 320 product websites visited

Complimentary ePharma Consumer® Data Snapshot
If you'd like to download a complimentary one-page snapshot of data and insights from the ePharma Consumer® v10.0 study, please visit http://www.manhattanresearch.com/research/data-snapshots/epharma-consumer-data-snapshot.aspx.

About ePharma Consumer® v10.0
ePharma Consumer® v10.0 was fielded online in Q4 2010 among 6,606 U.S. adults (ages 18+) who have gone online for pharma or prescription drug information in the past 12 months. This study also explores demand for adherence tools and services and the extent to which consumers leverage the Internet to lower drug spending. The study also provides key metrics for hundreds of pharma product websites.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm and conducts annual research studies covering eHealth trends among healthcare professionals and consumers.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions.

Most Popular Now

Positive new data for Johnson & Johnson single…

Johnson & Johnson (NYSE: JNJ) (the Company) announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly sp...

GSK and Alector announce global collaboration in i…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Alector (Nasdaq: ALEC), today announced a strategic global collaboration for the development and commercialisation of two clinical...

Tezepelumab granted Priority Review by U.S. FDA

Amgen (NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and granted Priority Review for tezepelu...

One shot of the Sputnik V vaccine triggers strong …

A single dose of the Sputnik V vaccine may elicit significant antibody responses against SARS-CoV-2, finds a study published July 13 in the journal Cell Reports Medicine...

Are silver nanoparticles a silver bullet against m…

Antimicrobials are used to kill or slow the growth of bacteria, viruses and other microorganisms. They can be in the form of antibiotics, used to treat bodily infections...

"Long COVID": More than a quarter of COV…

In a new study of adults from the general population who were infected with COVID-19 in 2020, more than a quarter report not having fully recovered after six to eight mon...

mRNA vaccines slash risk of COVID-19 infection by …

People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study of ...

Cancer cells eat themselves to survive

It is the membrane of cancer cells that is at the focus of the new research now showing a completely new way in which cancer cells can repair the damage that can otherwis...

U.S. FDA grants Priority Review for the Biologics …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) granted Priority Review designation for the Biologics Li...

Collaboration between AbbVie, Biogen and Pfizer cr…

The access to the world's largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequenc...

Artificial intelligence could be new blueprint for…

Writing in the July 12, 2021 online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses...

Anti-tumor agent from the intestine

It is believed to be involved in the development of chronic inflammatory intestinal diseases, to trigger diabetes, to be responsible for obesity, even neurological diseas...